1. ALDH7A1 expression is associated with recurrence in patients with surgically resected non-small-cell lung carcinoma. (May 2013) Authors: Giacalone, Nicholas J; Den, Robert B; Eisenberg, Rosana; Chen, Heidi; Olson, Sandra J; Massion, Pierre P; Carbone, David P; Lu, Bo Journal: Future oncology Issue: Volume 9:Number 5(2013) Page Start: 737 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. ALDH7A1 expression is associated with recurrence in patients with surgically resected non-small-cell lung carcinoma. (May 2013) Authors: Giacalone, Nicholas J; Den, Robert B; Eisenberg, Rosana; Chen, Heidi; Olson, Sandra J; Massion, Pierre P; Carbone, David P; Lu, Bo Journal: Future oncology Issue: Volume 9:Number 5(2013) Page Start: 737 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cancer therapy by restoration of immune Notch. (7th November 2013) Authors: Shanker, Anil; Dudimah, Duafalia F; Uzhachenko, Roman V; Biktasova, Asel K; Carbone, David P; Dikov, Mikhail M Journal: Journal for immunotherapy of cancer Issue: Volume 1(2013)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cancer therapy by resuscitating Notch immune surveillance. (24th February 2014) Authors: Shanker, Anil; Dudimah, Duafalia F; Pellom, Samuel T; Uzhachenko, Roman V; Carbone, David P; Dikov, Mikhail M Journal: Journal for immunotherapy of cancer Issue: Volume 2(2014)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Durable responders in advanced NSCLC with elevated TMB and treated with 1L immune checkpoint inhibitor: a real-world outcomes analysis. Issue 1 (17th January 2023) Authors: Huang, Richard S P; Carbone, David P; Li, Gerald; Schrock, Alexa; Graf, Ryon P; Zhang, Liangliang; Murugesan, Karthikeyan; Ross, Jeffrey S; Tolba, Khaled; Sands, Jacob; Oxnard, Geoffrey R; Spigel, David Journal: Journal for immunotherapy of cancer Issue: Volume 11:Issue 1(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Erlotinib, cabozantinib, or erlotinib plus cabozantinib as second-line or third-line treatment of patients with EGFR wild-type advanced non-small-cell lung cancer (ECOG-ACRIN 1512): a randomised, controlled, open-label, multicentre, phase 2 trial. Issue 12 (December 2016) Authors: Neal, Joel W; Dahlberg, Suzanne E; Wakelee, Heather A; Aisner, Seena C; Bowden, Michaela; Huang, Ying; Carbone, David P; Gerstner, Gregory J; Lerner, Rachel E; Rubin, Jerome L; Owonikoko, Taofeek K; Stella, Philip J; Steen, Preston D; Khalid, Ahmed Ali; Ramalingam, Suresh S Journal: Lancet oncology Issue: Volume 17:Issue 12(2016:Dec.) Page Start: 1661 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial. Issue 2 (February 2021) Authors: Paz-Ares, Luis; Ciuleanu, Tudor-Eliade; Cobo, Manuel; Schenker, Michael; Zurawski, Bogdan; Menezes, Juliana; Richardet, Eduardo; Bennouna, Jaafar; Felip, Enriqueta; Juan-Vidal, Oscar; Alexandru, Aurelia; Sakai, Hiroshi; Lingua, Alejo; Salman, Pamela; Souquet, Pierre-Jean; De Marchi, Pedro; Martin... Journal: Lancet oncology Issue: Volume 22:Issue 2(2021) Page Start: 198 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Highlights from the latest articles in lung cancer personalized medicine. (June 2014) Authors: Rivas-Perez, Hiram; Carbone, David P; Nana-Sinkam, S. Patrick Journal: Personalized medicine Issue: Volume 11:Number 4(Year 2014) Page Start: 377 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Longitudinal plasma proteomic profiling of patients with non-small cell lung cancer undergoing immune checkpoint blockade. Issue 6 (19th June 2022) Authors: Harel, Michal; Lahav, Coren; Jacob, Eyal; Dahan, Nili; Sela, Itamar; Elon, Yehonatan; Raveh Shoval, Shani; Yahalom, Galit; Kamer, Iris; Zer, Alona; Sharon, Ofer; Carbone, David P; Dicker, Adam P; Bar, Jair; Shaked, Yuval Journal: Journal for immunotherapy of cancer Issue: Volume 10:Issue 6(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Research Highlights: Highlights from the latest articles in translating genomics to clinical practice in lung cancer. (June 2013) Authors: de Lima Araujo, Luiz Henrique; Bissonnette, Adam; Carbone, David P; Nana-Sinkam, Patrick Journal: Personalized medicine Issue: Volume 10:Number 4(Year 2013) Page Start: 329 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗